The aim of this multicenter , prospective , randomized , crossover trial is to compare , in critical care patients receiving insulin infusion therapy ( IIT ) , the pharmacodynamic of Humulin insulin ( Hlin ) , currently used as `` standard of care , '' and Humalog insulin ( Hlog ) , a shorter acting insulin formulation .